Contact ANEUVO
ANEUVO would like to keep you up to date on our progress as we explore new ways of treating chronic injuries and conditions through neuromodulation.
ANEUVO Headquarters
10940 Wilshire Blvd., Suite 2030
Los Angeles, CA 90024 USA
+1 (424) 256 2194
contactus@aneuvo.com
ANEUVO Receives FDA Clearance for ExaStim®
U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...
Read more
ANEUVO Receives FDA Clearance for ExaStim®
U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...
Read more
Investigational therapy helps Easthampton man regain movement after spinal cord injury
EASTHAMPTON, MA (WGGB/WSHM) -- Nearly a decade after a training ride crash left him with a spinal cord injury, an Easthampton man is regaining function...
Read more
ANEUVO Secures Series C Funding to Strengthen ExaStim® Regulatory Readiness and Global Operational Scale
Proceeds to support manufacturing growth, regulatory advancement, and disciplined commercialization expansion Los Angeles, CA, March 05, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company...
Read more
ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim® Neuromodulation Technology
Honor highlights international startup advancing non-invasive rehabilitation technology for people living with chronic spinal cord injury Los Angeles, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) --...
Read more
ANEUVO Showcases ExaStim® Therapy At RehaCare 2025 and ISCoS 2025
The first MDR-Approved Non-Invasive Spinal Stimulation System in Europe Los Angeles, CA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ANEUVO today announced its participation in two...
Read more
ANEUVO’s ExaStim® Earns CE Mark Certification
Key Milestone Signals Readiness for European Market Entry and Commitment to Quality Los Angeles, CA, April 09, 2025 (GLOBE NEWSWIRE) -- ANEUVO, a pioneer in...
Read more
ANEUVO Launches ASPIRE™ Home Study to Evaluate Home Use of ExaStim®
This new phase of clinical research will test the safety and feasibility of ANEUVO’s non-invasive therapy for future use by individuals living with chronic spinal...
Read more
